Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

NVAX has a Moderate Buy rating on Wall Street based on two Buy, two Hold, and zero Sell ratings over the past three months. NVAX’s average price target of $14.25 implies a mammoth 113% upside ...

Novavax shows financial improvement but faces vaccine challenges. Read why I rated NVAX stock as 'Hold' and what risks and ...

Respiratory syncytial virus (RSV) is a leading cause of infant hospitalization, with the greatest impact on infants under 6 months of age. Most RSV hospitalizations occur in healthy infants ...

Federal regulators are asking Novavax to complete an additional randomized clinical trial on its Covid-19 vaccine after ...

The COVID vaccine brought a renewed public debate around vaccines. A new film airing on PBS explores the politicization of ...

A middle school student north of Dallas has tested positive. Meanwhile, Illinois has confirmed its first case in the state. Plus: A study in mice shows that covid is still contagious a week or more ...

On a recent call with analysts at BMO Capital Markets, a “former director” at the FDA’s Center for Biologics Evaluation and ...

The HHS chief, who has long argued that vaccines cause autism, dismissed the notion that "better diagnoses, better recognition, or changing diagnostic criteria" are driving up figures. Also, the CDC's ...

$50,000 of NOVAVAX INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Guidance navigating vaccine policy." ...

ATLANTA (AP) — A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as another option to protect teens against meningitis. FDA ...